SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001600132-19-000031
Filing Date
2019-01-23
Accepted
2019-01-23 17:05:22
Documents
6
Period of Report
2019-01-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kjan2019offering.htm 8-K 33111
2 EXHIBIT 1.1 a8-kjan2019offeringex11.htm EX-1.1 233035
3 EXHIBIT 5.1 a8-kjan2019offeringex51.htm EX-5.1 16880
4 EXHIBIT 99.1 a8-kjan2019offeringex991.htm EX-99.1 11459
5 EXHIBIT 99.2 a8-kjan2019offeringex992.htm EX-99.2 11318
6 mintzlevina15.jpg GRAPHIC 117377
  Complete submission text file 0001600132-19-000031.txt   468722
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36845 | Film No.: 19537998
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1